The regulation of the expression of the 3 retinoid receptors type A (RAR-α, -β, and -γ) in the progession to prostate cancer has been partially addressed by Richter, et al., who showed the differential effects of all-trans retinoic acid in human prostate cancer lines [34,35]. Here, RARA is linked to prostate carcinoma.